MAPK14 and neurodegenerative disease: As we have previously shown that EP protein levels can be controlled by other factors40, methods for attenuating EP expression could be sought to be a potential drug target, as is the use of p38 MAP kinase inhibitors or ROS scavengers, which are also being sought to be used in neurodegenerative diseases.